TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

EXIQON SEEK FIND VERIFY

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

EXIQON SEEK FIND VERIFY

ST13

US500000079062177

Classe

1, 5, 42, 45

Pedido

79062177

Registro

3810965

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

57

Atualização mais recente

14/01/2022

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

1, 5, 42, 45

Data de depósito

28/10/2008

Data de registro

29/06/2010

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

26/02/2021

Última transação

26/02/2021

Escritório responsável

United States Patent and Trademark Office

Código da situação

709

Cadastro oficial

Principal Register

Código do desenho

5

Tipo de titular

98

Localização do titular

DE

Examinador

CORWIN, KEVIN

Unidade examinadora

M30

Descrição da marca

The mark consists of the wording "EXIQON" appearing above the words "Seek Find Verify" with all the aforementioned wording appearing in the color blue.

Titulares e representantes

Titulares

QIAGEN GmbH
Exiqon A/S

Representantes

LEIGH ANN LINDQUIST SUGHRUE MION, PLLC

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 42Classe 45

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemical products for diagnostic, industrial and scientific purposes, namely, industrial chemicals, catalysts for chemical and biochemical processes and chemicals used in the manufacture of pharmaceuticals and drug candidates, all of the aforementioned being for use in life science research, for use in the manufacture of anti-cancer drugs and drug candidates, and for use in in vitro diagnostics and in molecular and cancer diagnostics not for medical or veterinary purposes; Biochemical products for analyses of nucleic acids, nucleotides, oligonucleotides, DNA and RNA, namely, biochemical catalyst, biochemical reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays not for medical or veterinary purposes, and molecular and cell-based oncology assays not for medical and veterinary purposes; Chemical reagents not for medical or veterinary purposes; Biochemical kits, consisting of biochemical preparations in the nature of biochemical catalysts, biochemical reagents commonly known as probes, and enzymes, for analysis of genes, nucleic acids, nucleotides, oligonucleotides, DNA, RNA and microRNA not for medical or veterinary purposes; Biochemical reagents, commonly known as probes for analyses of DNA, RNA, nucleotides, oligonucleotides, nucleic acids and for detecting RNA and microRNA not for medical or veterinary purposes

Classe 5

Chemical preparations for pharmaceutical, medical and veterinary use, namely, clinical medical reagents, diagnostic reagents, and assays for medical use; Chemico-pharmaceutical preparations, namely, biomedical preparations and assays for use in the detection of cancer in humans and animals and for use in oncology and pharmaceutical preparations for use in the prevention, treatment and cure of cancer; Chemical reagents for medical and veterinary purposes; Chemical preparations for medical therapeutic purposes, namely, preparations for the detection of cancer in humans and animals, for the treatment, prevention and cure of cancer, and for use in oncology; Diagnostic preparations for medical and veterinary purposes

Classe 42

Scientific research, development and consultancy relating thereto in the fields of chemical analyses of genes, nucleic acids, nucleotides, oligonucleotides, DNA, RNA and microRNA; Biotechnological consultancy relating to DNA peptide and nucleotide syntheses

Classe 45

[ Licensing of intellectual property rights, including patent utilisation concerning chemical analyses of genes, nucleic acids, nucleotides, oligonucleotides, DNA, RNA and microRNA; Consultancy services concerning the issuing of intellectual property rights licenses, and of licenses relating to the use of genes, nucleic acids, nucleotides, oligonucleotides, DNA, RNA and microRNA ]

Publicações

Histórico de despachos e eventos da marca no USPTO.

57 publicações encontradas

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

14/01/2022

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

16/12/2021

INPC

INVALIDATION PROCESSED

16/12/2021

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

26/10/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/04/2021

C71T

CANCELLED SECTION 71

26/02/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/01/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/01/2020

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

29/06/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

19/04/2019

CHLD

CHANGE OF OWNER RECEIVED FROM IB

15/03/2019

RNWL

INTERNATIONAL REGISTRATION RENEWED

12/04/2018

NREP

NEW REPRESENTATIVE AT IB RECEIVED

30/06/2017

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

23/06/2017

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

02/03/2017

XXCR

GENERIC MADRID TRANSACTION CREATED

02/03/2017

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

27/12/2016

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

27/04/2016

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

27/04/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

27/04/2016

ES75

TEAS SECTION 71 & 15 RECEIVED

04/03/2016

NREP

NEW REPRESENTATIVE AT IB RECEIVED

27/11/2015

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/02/2013

FICS

FINAL DISPOSITION NOTICE SENT TO IB

06/10/2010

FIMP

FINAL DISPOSITION PROCESSED

06/10/2010

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

29/09/2010

R.PR

REGISTERED-PRINCIPAL REGISTER

29/06/2010

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

04/06/2010

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

14/05/2010

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

13/05/2010

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

13/04/2010

PUBO

PUBLISHED FOR OPPOSITION

13/04/2010

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/03/2010

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/03/2010

XAEC

EXAMINER'S AMENDMENT ENTERED

10/03/2010

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

10/03/2010

GNEA

EXAMINERS AMENDMENT E-MAILED

10/03/2010

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/03/2010

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

25/02/2010

ALIE

ASSIGNED TO LIE

25/02/2010

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

24/02/2010

CNFR

FINAL REFUSAL MAILED

08/10/2009

CNFR

FINAL REFUSAL WRITTEN

07/10/2009

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

25/08/2009

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

25/08/2009

ALIE

ASSIGNED TO LIE

25/08/2009

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/08/2009

RFNT

REFUSAL PROCESSED BY IB

06/03/2009

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/02/2009

RFRR

REFUSAL PROCESSED BY MPU

10/02/2009

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/02/2009

CNRT

NON-FINAL ACTION WRITTEN

09/02/2009

DOCK

ASSIGNED TO EXAMINER

29/01/2009

MAFR

APPLICATION FILING RECEIPT MAILED

19/12/2008

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

18/12/2008

NWAP

NEW APPLICATION ENTERED

15/12/2008

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

12/12/2008

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace EXIQON SEEK FIND VERIFY ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.